Angiotensin receptor blockers for heart failure
30 results
1 - 30
Angiotensin receptor blockers for heart failure- Nurse‐led titration of angiotensin converting enzyme inhibitors, beta‐adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction
- Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
- LCZ696 (sacubitril/valsartan) for patients with heart failure
- Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
- First‐line diuretics versus other classes of antihypertensive drugs for hypertension
- Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients
- Calcium channel blockers versus other classes of drugs for hypertension
- First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review
- Renin inhibitors versus angiotensin receptor blockers for primary hypertension
- Digitalis for treatment of heart failure in patients in sinus rhythm
- Pharmacological interventions for heart failure in people with chronic kidney disease
- Perioperative angiotensin‐converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults
- Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non‐diabetic chronic kidney disease
- Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks: Cochrane systematic review
- Higher blood pressure targets for hypertension in older adults
- Natriuretic peptide‐guided treatment for the prevention of cardiovascular events in patients without heart failure